Introduction. Pulmonary arterial hypertension (PAH) is a major cause of mortality in SSc. NT-proBNP may be a useful biomarker of prevalent PAH but its role in screening for incident PAH has not been evaluated.
Conclusions. These results confirm the poor prognosis for incident and newly diagnosed SSc-PAH patients even in the modern era of treatment. NYHA functional class, age and presence of an ILD at the diagnosis of PAH were important prognosis factors. Poor right ventricular haemodynamic function and desaturation during the 6-min walk test were also associated with mortality. As 80% of patients are still diagnosed with an NYHA function Class III/IV which appears as one of the most important prognosis factor, screening allowing an earlier diagnosis should be a priority. (14) years, and at first nonRaynaud symptom 51 (16) years. Mean disease duration was 18 (6) months and time between the onset of Raynaud and first non-Raynaud symptom was 3 (7) months. PH-echo was present in 184 (18%) patients. PH was highly associated (P < 0.0001 for all) with older age, lung involvement (lung fibrosis, restriction, low DL CO ), cardiac involvement (cardiac blocks, LV systolic and diastolic dysfunction) and very active disease (EUSTAR activity index, acute-phase response, ischaemic ulcers, joint contractures, muscular atrophy, high mRSS). To a lesser extent is also associated with renal involvement (renal crisis P ¼ 0.01; high blood pressure P ¼ 0.05; proteinuria P < 0.0001). The results are similar when the subgroups of diffuse disease, limited disease, males, females or patients with disease duration <1 year were analysed. Conclusions. In early SSc patients, PH-echo is present in patients with very active disease, showing cardiac, lung and renal involvement. Although some of these patients might present true PAH, others may have PH secondary to lung or left heart involvement. Since treatment for PH of different causes is not the same, our findings emphasize the need to perform right heart cathetherization to clearly diagnose the cause of PH in every SSc patient. Fig. 1 shows the time to PH was 11% at 2 years, 15% at 3 years and 30% at 4 years. There were no statistically significant demographic features in the 32 PH þ subjects compared with the Non-PH group (Table 1) . At baseline, the PH þ group had a significantly lower 6-min walk distance and significantly more exercise-induced hypoxia than the non-PH group. The PH þ group had lower entry %DL CO and higher FVC%/DLCO %, though this did not reach statistical significance. The mean echo sPAP at entry in the PH þ group was significantly higher (OR ¼ 2.37, 95% CI 1.1, 5.1), and subsequently increased to 54.1 (18.0) mmHg, leading to RHC. Thirteen of these patients [whose mean echo sPAP was 47 (10.3) mmHg] had an initial normal RHC [mPAP 21.2 (2.8) mm Hg], but subsequently developed PH. Overall, 66 of the 246 patients had a normal RHC; their mean echo sPAP was 40 (11.3) mmHg which was significantly higher than the RHC sPAP [30.2 (5.6) mmHg, P < 0.001]. Conclusion. PH was confirmed in 13% of these high-risk patients, with 30% developing PH 4 years after entry. Exercise hypoxia and an entry echo sPAP > 40 were strongly associated with future PH. However, frequent false elevations in echo sPAP required an RHC to confirm PH. Results. Sixty-nine (42%) patients showed a significant exerciseinduced increase in PASP. Among them, peak PVR !3 WU were present only in 11% of patients, which is $5% of the total population. Univariate analysis showed that age, presence of interstitial lung disease (ILD) and both right and left diastolic dysfunction are predictors of peak PASP !50 mmHg, but none of these parameters predict elevated peak PVR.
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Conclusions. Exercise-induced increase in PASP occurs in almost one-half of SSc patients with normal resting PASP. Peak exercise PASP is affected by age, ILD and right and left ventricular diastolic dysfunction, and only in 5% of the patients is associated to an increase in PVR during exercise, suggesting heterogeneity of the mechanisms underlining exercise-induced PH in SSc. 
